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AbstrAct
Objective: In this study we evaluated the elastic properties of 
the aorta in patients with subclinical hypothyroidism and their 
relation with left ventricular diastolic function by transthoracic 
echocardiography. 
Patients and Methods: Aortic transthoracic echocardiography 
was performed and the aortic elasticity was evaluated using the 
following parameters; strain, the beta index and distensibility. 
results: There was significant difference in terms of aortic 
strain (5.79% vs. 9.45%  p <0.001) and distensibility (4.64 versus 
3.02 10-3.cm2. dyn-1. p <0.005) between the control group and 
patients with subclinical hypothyroidism group. In the subclinical 
hypothyroidism group the average mitral early diastolic velocity 
(E). (p <0.05) were significantly lower than the mean mitral 
diastolic flow velocity / mitral late diastolic flow velocity (E / A) 
(p <0.01) observed in the control group. and higher than the mean 
mitral late diastolic flow velocity (A) and isovolumetric relaxation 
time (IVRT) (P <0.05) in the control group. 
conclusions: In patients with subclinical hypothyroidism 
an increase in the aortic stiffness was observed. The diastolic 
dysfunction observed in subclinical hypothyroidism is mainly 
responsible for the increase in the aortic stiffness.
Keywords: Aortic stiffness. Subclinical hypothyroidism. Left 
ventricular diastolic dysfunction
ÖZEt
Amaç: Bu çalışmada. subklinik hipotiroidili hastalarda aortun 
elastikiyet özellikleri ve bunların sol ventrikül diyastolik 
fonksiyonu ile ilişkileri transtorasik ekokardiyografik metod ile 
araştırıldı. 
Hastalar ve Yöntemler: Transtorasik ekokardiyografi 
yapılarak aortun elastikiyet parametreleri olarak aortik strain. beta 
indeksi ve distensibilite indeksine bakıldı. 
bulgular: Kontrol grubu ve subklinik hipotiroidili hasta grubu 
arasında aortik strain (sırasıyla %9.45’e karşı %5.79. p<0.001) 
ve distensibilite (4.64’e karşı 3.02 10-3.cm2.dyn-1. p<0.005) 
yönünden anlamlı farklar vardı. Subklinik hipotiroidi grubunda 
mitral erken diyastolik akım hızı (E) ortalaması (p< 0.05). mitral 
diyastolik akım hızı/ mitral geç diyastolik akım hızı (E/A) (p<0.01) 
kontrol grubu ortalamasına göre anlamlı olarak düşük. mitral geç 
diyastolik akım hızı ortalaması (A) ve izovolümetrik relaksasyon 
zamanı ( IVRZ) (p< 0.05) kontrol grubu ortalamasına göre yüksek 
bulundu.
sonuç: Subklinik hipotiroidili hastalarda aortik stiffness’de 
artış gözlenmektedir. Subklinik hipotiroidili hastalarda gözlenen 
diyastolik fonksiyon bozukluğundan esas olarak aortik stiffness 
artışı sorumlu olabilir.
Anahtar kelimeler: Aortik stiffness. Subklinik hipotiroidizm. Sol 
ventrikül diyastolik disfonksiyonu 
Introduction
Subclinical hypothyroidism (SCH) is defined as thyroid 
dysfunction consisting of normal serum thyroid hormone 
levels and high thyroid stimulating hormone (TSH) 
[1.2]. The frequency of SCH varies between 4-10%. and 
incidence increases with age [3].  Chronic autoimmune 
thyroiditis (Hashimoto’s thyroiditis) has been identified in 
the etiology of 55% of SCH cases. Other common causes 
include thyroid ablation with radioactive iodine. partial 
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thyroidectomy. antithyroid drugs. and external radiotherapy. 
drugs such as amiodarone and lithium. radiocontrast agents. 
insufficient thyroid hormone replacement therapy in overt 
hypothyroidism [4]. Several epidemiological studies have 
reported that SCH may be a cardiovascular risk factor and 
increase the risk of aortic atherosclerosis and myocardial 
infarctions [5]. While some studies  [5-7] have determined a 
relationship between SCH and coronary artery disease. other 
studies  [8.9] have failed to do so.
Aortic stiffness (aortic stiffness) represents the 
mechanical tension and elasticity of the aorta wall. 
Several studies have shown that hypertension. diabetes. 
atherosclerosis. Marfan syndrome. smoking and aging 
increase aortic stiffness. Aortic elasticity is closely associated 
with cardiovascular mortality  [10]. Aortic distensibility 
(AD) and aortic strain (AS) constitute the elastic properties 
of the aorta and reflect aortic stiffness [11.12].  The 
evaluation of the mechanical properties of the aorta by 
non-invasive method provide great benefits for the early 
diagnosis of atheroma  [13] and increased aortic stiffness 
or decreased distensibility are widely used as an indicator 
of atherosclerotic involvement of the vascular system [14]. 
The objective of our study is to determine aortic stiffness 
parameters by means of transthoracic echocardiography in 
subclinical hypothyroidism patients and compare them with 
the group with normal thyroid function tests.
Patients and Methods
A total of 38 newly diagnosed patients with subclinical 
hypothyroidism admitted to the internal medicine outpatient 
clinics of Haydarpasa Numune Training and Research 
Hospital and a control group consisting of 20 healthy people 
with normal thyroid function tests were included in this 
prospective study. 
Patients with history of hypertension. diabetes mellitus. 
hyperlipidemia. a history of acute coronary syndrome 
in the last six months. heart valve disease. congenital 
heart disease. left ventricular dysfunction (left ventricular 
ejection fraction <50%). inflammatory disease. kidney 
and liver disease. use of drugs that affect thyroid hormone 
levels (propylthiouracil. methimazole. glucocorticoids. 
lithium. amiodarone. propranolol. radioiodine therapy). 
hypothyroidism and hyperthyroidism history. thyroid 
surgery. undergoing pregnancy. pituitary and hypothalamic 
disease. a history coronary artery disease or a positive 
exercise electrocardiography or positive perfusion 
test. arrhythmia. aortic vascular disease. hypertrophic 
cardiomyopathy. malignancy. congestive heart failure. 
previous history of stroke. intermittent claudication. 
chronic obstructive pulmonary disease. smoking. use of oral 
contraceptives or estrogen replacement therapy. and with 
insufficient echocardiography image were excluded from 
the study.
All patients were informed about the study and informed 
consent was obtained from them. The study was approved 
by the local ethics committee.
The normal range of thyroid function tests and thyroid 
stimulating hormone (TSH) in our center were as follows: 
0.27 to 4.20 IU / ml for TSH. 1.80 to 4.60 pg / ml for free 
T3 (FT3) and 0.93 to 1.70 ng / dl for free T4 (FT4). SCH 
was defined as a value of TSH> 4.94 IU/mL. with normal 
free hormone levels. Blood samples after 12 hours of fasting 
were collected from all cases and total cholesterol (mg / dL). 
triglycerides (mg / dL). high density lipoprotein cholesterol 
(HDL-cholesterol) (mg / dL). low density lipoprotein 
cholesterol (LDL-cholesterol) (mg / dl). serum TSH (IU / 
ml). FT3 (pg / ml). FT4 (ng / dl). alanine aminotransferase 
(ALT) (U/L). aspartame aminotransferase (AST) (U/L) and 
creatine kinase (mg / dl) were measured. The measurement 
of the parameters was performed in the central biochemistry 
laboratory of Haydarpasa Numune Training and Research 
Hospital. using “Roche Modular System E-170” (Japan) 
device. The height and weight of the patient was measured 
and body mass index (BMI) was calculated as the ratio 
of weight to height squared (kg / m2). The patients’ blood 
pressure was measured with sphygmomanometer before the 
echocardiography.
transthoracic echocardiography
Transthoracic echocardiography examination by ESAOTE 
7000 CFM color Doppler echocardiography device and 
using 2.5-3.5 MHz transducer 78 was performed to all the 
cases in the patients and the control group in left lateral 
decubitus position. All echocardiographic measurements 
were carried out in three consecutive cycles and their 
average was taken. M-mode recordings were performed with 
50 mm / sec and the Doppler recordings with 100 mm / sec 
velocity. M-mode measurements and conventional Doppler 
measurements. deceleration time (DT). isovolumetric 
relaxation time (IVRT). mitral early diastolic flow time 
(E). mitral late diastolic flow time (A) transmitral flow 
velocity ratio (E / A) were performed according to the 
American Echocardiography Society proposals [15]. In 
order to calculate aortic tension and distensibility. systolic 
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and diastolic diameters of the ascending aorta was measured 
with M-mode echocardiography approximately 3 cm above 
the aortic valve in parasternal long axis [16]. The systolic 
diameter of the aorta was measured at the point of maximum 
forward movement of the aorta and the diastolic diameter 
was measured on the area corresponding to the peak of the 
QRS complex in the electrocardiogram. Measurements were 
repeated during three cardiac beats and the average value 
was taken.
Calculation of aortic elasticity parameters: as the aortic 
elasticity parameters aortic strain. the beta index and 
distensibility [17] were included. The following formulas 
were used in the calculation of the parameters:
Aortic Strain (%) = (systolic diameters - diastolic 
diameter) x 100 / diastolic diameter
Beta index = IN (systolic / diastolic pressure) / aortic 
strain
Distensibility (cm² / dyne -1) = 2 (aortic strain) / (systolic 
pressure-diastolic pressure)
statistical evaluation
For statistical analysis of the results obtained in the study 
SPSS Statistical Package for Social Sciences (SPSS) for 
Windows 10.0 program was used. When evaluating the 
studys’ data in addition to descriptive statistical methods. 
(mean. standard deviation) for the comparison of quantitative 
parameters with normal distribution Student’s t test was used 
and comparison of parameters without normal distribution 
Mann-Whitney U test was used. Pearson correlation test 
was used to examine the relationship between parameters. 
Results were evaluated in the 95% confidence interval and 
p <0.05 level.
results
A total of 38 patients diagnosed with subclinical 
hypothyroidism and 20 people with normal thyroid 
function tests and lipid profile were enrolled in the study 
group. Normal distribution of age and gender groups was 
established between groups. The mean age of the patients 
was 41.29 ± 12.82 years. Among 38 patients with subclinical 
hypothyroidism 8 were men (20%) and 30 women (80%) 
and out of 20 cases in the control group 4  were men 
(20%) and 16  women (80%). respectively. There was no 
statistically significant difference between the groups in 
terms of age (p <0.05). The average level of aortic strain 
and distensibility of the SCH group was found significantly 
lower compared to the control group (p <0.01) (Table I). A 
significant difference was found between SCH patients and 
control group in terms of aortic strain (5.79% vs. 9.45%  p 
<0.001) and distensibility (4.64 versus 3.02 10-3.cm2.dyn- 
1. p <0.005). In the subclinical hypothyroidism group the 
average mitral early diastolic velocity (E). (P <0.05) were 
significantly lower than the mean mitral diastolic flow 
velocity / mitral late diastolic flow velocity (E / A) (p <0.01) 
observed in the control group. and higher than the mean 
mitral late diastolic flow velocity (A) and isovolumetric 
relaxation time (IVRT) (p <0.05) in the control group. 
(Table II).
table I. The findings of aortic strain and distensibility in the control 
and subclinical hypothyroid group
scH group
(n=38)
control group
(n=20)
Aortic strain (%) 5.79±4.10 9.45±3.24 t:-3.454
p:0.001**
Distensibility
(cm²/dyn/10³)
3.02±2.25 4.64± 1.50 t:-2.898;
p:0.005**
**p value of  p< 0.01 was considered as statistically significant.  t: Student’s t test
SCH: Subclinical hypothyroidism
table II. The clinical and echocardiographic findings in SCH and control
scH (n=38) control (n=20)
Age (year) 42±15 38±6 t:1.533; p:0.131
E(m/s) 7.18±2.32 8.30±1.26 t:-1.993;
p:0.050*
A(m/s) 6.68±2.34 6.20±1.15 U:255.5;
P:0.037*
E/A 10.05±4.12 13.95±4.47 t:-3.327;
p:0.002**
IVRZ(ms) 102.89±29.90 88.15±19.73 t:1.985;
p:0.050*
DT(ms) 159.55±42.84 147.65±35.97 t:1.060; p:0.294
ASD(mm) 28.82±3.96 29.19±4.47 t:-0.320; p:0.750
ADD(mm) 26.14±4.08 25.88±4.38 U:354.5; 
P:0.676
TSH(µIU/ml) 7.78±2.60 2.30±0.81 t:11.919;
p:0.001**
* p value of p<0.05 was considered as statistically significant
** p value p<0.01 was considered as statistically significant 
 t: Student’s t test.  U: Mann Whitney U test.  
SCH: subclinical hypothyroidism. E: mitral early diastolic velocity (E). A: 
mitral late diastolic flow velocity (A). E/A: mitral early diastolic velocity / 
mitral late diastolic flow velocity (E / A).  IVRZ: isovolumetric relaxation 
time. DT: deceleration time. ASD: systolic diameters ADD: diastolic 
diameter. TSH: thyroid stimulating hormone
138 Ozkan et al
Aortic elasticity in subclinical hypothyroidism Marmara Medical Journal 2015; 28: 135-141
A 47.6%. statistically significant negative correlation 
was found between age and distensibility (p <0.01). A 
statistically significant positive correlation of 37.1% was 
found between E and distensibility (p <0.05). A statistically 
significant relationship between distensibility and A. E / 
A was found (p> 0.05). A statistically significant negative 
correlation of 43.2% was found between distensibility 
and IVRT (p <0.01). A statistically significant negative 
relationship between distensibility and DT delay time (DT) 
of 39.7% was found (p <0.05). No statistically significant 
correlation between distensibility and ASD. ADD and 
TSH levels was found (p> 0.05). A positive statistically 
significant correlation between FT3 and distensibility. 
at the level of 34.5% was found (p <0.05). There was no 
statistically significant relation between distensibility and s 
T4 (p> 0.05) (Table III).
table III. Correlations of distensibility  
Distensibility
r p
Age (year) -0.476 0.003**
Aortic strain 0.913 0.001**
E(m/s) 0.371 0.022**
A(m/s) 0.070 0.677
E/A (m/s) 0.160 0.336
IVrZ(ms) -0.432 0.007**
Dt(ms) -0.397 0.013*
AsD (mm) -0.160 0.337
ADD (mm) -0.187 0.262
tsH(µIU/  ml) -0.224 0.176
*p value of p<0.05 was considered as statistically significant
**p value p<0.01 was considered as statistically significant 
r: Pearson correlation coefficient
SCH: subclinical hypothyroidism. E: mitral early diastolic velocity (E). A: 
mitral late diastolic flow velocity (A). E/A: mitral early diastolic velocity / 
mitral late diastolic flow velocity (E / A) .  IVRZ: isovolumetric relaxation 
time. DT: deceleration time. ASD: systolic diameters ADD: diastolic 
diameter. TSH: thyroid stimulating hormone
Discussion
The results of this study indicated that in patients with 
subclinical hypothyroidism. through the transthoracic 
echocardiography. which is a noninvasive diagnostic 
method. the aortic distensibility. which is the indicative 
of the aortic stiffness. is decreased and the aortic stiffness 
is increased. and the aortic elasticity parameters are the 
strongest predictor of left ventricular diastolic function.
Cardiovascular system is one of the major systems affected 
by thyroid hormone. The most important changes  observed 
in the cardiovascular system in patients with hypothyroidism 
are increased vascular resistance. diastolic dysfunction. 
reduction of cardiac preload and decreased systolic 
function [12]. In a study conducted by echocardiography. 
isovolumetric relaxation time was found to be longer in 
patients with subclinical hypothyroidism [13]. In different 
studies. an increase was observed  in coronary artery disease 
and cardiovascular mortality in SCH patients [18.19]. The 
reduction in myocardial contractility and heart rate in SCH 
patients leads to a decreased cardiac output and exercise 
tolerance. In addition. in these patients an increase in the 
systemic vascular resistance and extracellular volume and 
diastolic dysfunction as a result of endothelial dysfunction 
develops [20].  The diastolic function in SCH patients was 
assessed by Biondi and friends for the first time with Doppler 
echocardiography and myocardial relaxation anomalies were 
found. Following 6 months thyroid replacement therapy in 
these patients a normalization of IVRZ and decrease of E / 
A ratio was found [21]. In a prospective study conducted 
by Niafar et al evaluating cardiac functions in SCH women 
and healthy subjects it was found that SCH could lead to the 
left ventricle diastolic dysfunction [22]. There is evidence 
that shows the negative effects of increased stiffness of large 
arteries on cardiovascular outcomes [17]. In the Framingham 
study. the baseline and 20 years follow up increase of pulse 
pressure as marker of large artery stiffness. was strongly 
associated with coronary artery disease risk in elderly and 
middle-aged population without clinical history of coronary 
artery disease [23].
Aortic stiffness is a predictor of all-cause mortality in 
cardiovascular disease independent of other risk factors such 
as age and diabetes. Many methods have been described in 
the evaluation of arterial stiffness. These techniques vary 
from quite a simple process such as brachial pulse pressure 
measurements which can be assessed by cuff to more detailed 
and complex techniques which may require hardware 
such as pulse wave velocity variables. determination 
of aortic impedance and aortic elastic coefficient. The 
measurement of pulsatile variability of the diameter of the 
aorta using an ultrasound catheter and invasive procedures 
provides information on aortic elasticity [24]. The pulsatile 
distensibility and variability of aorta can be assessed using 
a noninvasive method such as echocardiography [25]. 
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Increased arterial stiffness in fact is an important indicator 
of vascular aging  [26].
Many studies have reported that hypertension and diabetes 
decreased aortic strain and distensibility. How hypertension 
and diabetes induce an increase in aortic stiffness is not 
known. However. a possible mechanism; hypertension 
generates high pressure in the arterial wall leading to a 
number of structural changes and atherosclerosis. Diabetes 
causes the accumulation of glycosides in the arterial wall 
which are believed to form arteriosclerosis.       Regardless. 
the mechanism aortic vascular stiffness is related with high 
mortality in patients with diabetes mellitus and hypertension 
[11].  
The cardiovascular disease risk is more significant 
in clinical hypothyroidism than the SCH [27].  Some 
observational studies [28.29] have shown an increase risk of 
coronary heart disease in patients with SCH. But the results 
of other studies [30.31]  have shown that the increased 
coronary heart disease risk is not substantial. In SCH patients 
atherosclerosis risk factors such as hypertension. increased 
C-reactive protein levels. and changes in the coagulation 
system. endothelial dysfunction. and increased arterial 
stiffness and thermogenic lipid profile are also present [32] .
Dyslipidemia may cause some changes in the elasticity 
of the arterial wall [28].  Several studies have shown a 
relationship between SCH and atherogenic lipid profile 
[33.34].  When compared with euthyroid patients. elevated 
serum triglycerides and LDL-C levels have been reported in 
SCH patients [35]. In our study. in order to evaluate aortic 
stiffness and distensibility. transthoracic echocardiography 
has been performed in 38 SCH patients and 20 patients with 
a normal thyroid function tests. Patients without history 
of factors that affects aortic stiffness such hypertension. 
hypercholesterolemia. diabetes. coronary artery disease. 
cerebrovascular disease. liver disease and renal failure 
have been selected. There was no statistically significant 
difference between the SCH and control group in terms of 
age (p> 0.05). 
We found that the non-invasive diagnostic methods 
aortic distensibility and aortic strain level in SCH patients 
were significantly lower than the control group. In studies 
conducted before it has been found that SCH affects left 
ventricular diastolic dysfunction and arterial stiffness 
[36.21].  Statistically.  a significant negative relationship 
between distensibility and age and IVRT  between 
significant positive  relationship between aortic strain and E 
was found (p <0.01). (Table III).
In a  study conducted by Mishra et al.  echocardiography 
findings of SCH patients and control group were compared 
[37]. The results were similar to our study.  The mean IVRZ 
and A was found higher and E/A ratio lower in SCH patients 
respectively (p <0.05). After a year of hormone replacement 
therapy. an improvement in the left ventricular diastolic 
function has been found in patients with SCH [37].  In a study 
investigating the effect of low dose L-thyroxine therapy over 
left ventricular diastolic function in SCH patients. the E and 
E / A ratio were found lower in the SCH patients compared 
to the healthy control group [38]. 
The positive effects of thyroid replacement therapy on 
arterial stiffness in patients with SCH have been shown in 
several studies. In a study evaluating myocardial reserve and 
arterial stiffness. arterial stiffness was observed to decrease 
following six months of treatment [39]. 
Several studies have shown that arterial stiffness is a 
major cause of cardiovascular complications. The presence 
of atherosclerotic lesions in the aortic wall may contribute 
to decreased elasticity of the ascending aorta. Therefore. 
the degradation of the arterial blood vessel elasticity 
can facilitate the formation of atherosclerosis [40].  In a 
recent study. it was reported that SCH associated with 
left ventricular diastolic dysfunction and arterial stiffness 
may be a risk factor for cardiovascular events [41].   In the 
study conducted by Yurtdaş et al. the aortic elastic features 
were investigated using tissue Doppler imaging; aortic 
distensibility in patients with SCH was statistically lower 
than euthyroid patients (p <0.001) and aortic stiffness index 
was significantly higher in patients with SCH (p <0.001) 
[42].   In this study. similar to ours it was shown that stiffness 
index is high in patients with SCH and aortic distensibility is 
lower than the control group.
Masaki et al. in their study showed that SCH associated 
with left ventricle diastolic dysfunction and arterial stiffness 
may increase cardiovascular events [41]. In our study. the 
aortic strain and distensibility of SCH was found to be lower 
than the control group.
In conclusion. our study has shown that SCH is associated 
with left ventricular diastolic dysfunction and decrease 
in the elastic properties of the aorta. The aortic stiffness 
evaluated by means of echocardiography is increased in 
patients with SCH. An indicator of early vascular aging. 
arterial stiffness. can be easily measured by non-invasive 
transthoracic echocardiography. It is a method that can be 
easily assessed and provide more intensive treatment of 
risk factors therefore reducing cardiovascular diseases and 
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mortality. The reduction of the elastic properties of the aorta 
may play a causal role in the development of increased 
afterload and left ventricle diastolic dysfunction. The aortic 
elasticity parameters measured by non-invasive methods 
may be useful in early prevention and prediction of the risk 
of cardiovascular disease. However. prospective studies 
with more patients are needed.
Limitations of the study
The small number of SCH patients and control group and 
the lack of TSH levels or subgroup analysis are the main 
potential limitation to our study. Therefore. long-term 
prospective studies including a larger number of patients are 
needed. 
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